These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16990839)

  • 1. Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention.
    Navab M; Anantharamaiah GM; Reddy ST; Fogelman AM
    Nat Clin Pract Cardiovasc Med; 2006 Oct; 3(10):540-7. PubMed ID: 16990839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
    Sherman CB; Peterson SJ; Frishman WH
    Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM
    Curr Opin Lipidol; 2004 Dec; 15(6):645-9. PubMed ID: 15529023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential clinical utility of high-density lipoprotein-mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM
    Curr Opin Lipidol; 2006 Aug; 17(4):440-4. PubMed ID: 16832169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-I mimetic peptides.
    Van Lenten BJ; Wagner AC; Anantharamaiah GM; Navab M; Reddy ST; Buga GM; Fogelman AM
    Curr Atheroscler Rep; 2009 Jan; 11(1):52-7. PubMed ID: 19080728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.
    Wool GD; Reardon CA; Getz GS
    J Lipid Res; 2008 Jun; 49(6):1268-83. PubMed ID: 18323574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological properties of apolipoprotein a-I mimetic peptides.
    Getz GS; Wool GD; Reardon CA
    Curr Atheroscler Rep; 2010 Mar; 12(2):96-104. PubMed ID: 20425244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.
    Smythies LE; White CR; Maheshwari A; Palgunachari MN; Anantharamaiah GM; Chaddha M; Kurundkar AR; Datta G
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1538-48. PubMed ID: 20219948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Yu N; Ansell BJ; Datta G; Garber DW; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1325-31. PubMed ID: 15831812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of HDL mimetic peptide 4F on PON1.
    Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
    Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
    Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
    Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Wagner AC; Hama S; Hough G; Bachini E; Garber DW; Mishra VK; Palgunachari MN; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1932-7. PubMed ID: 15961700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Hama S; Hough G; Reddy ST; Frank JS; Garber DW; Handattu S; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1426-32. PubMed ID: 15845909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease.
    Ou J; Ou Z; Jones DW; Holzhauer S; Hatoum OA; Ackerman AW; Weihrauch DW; Gutterman DD; Guice K; Oldham KT; Hillery CA; Pritchard KA
    Circulation; 2003 May; 107(18):2337-41. PubMed ID: 12732610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides.
    Gomaraschi M; Calabresi L; Rossoni G; Iametti S; Franceschini G; Stonik JA; Remaley AT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):776-83. PubMed ID: 18042829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.
    D'Souza W; Stonik JA; Murphy A; Demosky SJ; Sethi AA; Moore XL; Chin-Dusting J; Remaley AT; Sviridov D
    Circ Res; 2010 Jul; 107(2):217-27. PubMed ID: 20508181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice.
    Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.
    Anantharamaiah GM; Mishra VK; Garber DW; Datta G; Handattu SP; Palgunachari MN; Chaddha M; Navab M; Reddy ST; Segrest JP; Fogelman AM
    J Lipid Res; 2007 Sep; 48(9):1915-23. PubMed ID: 17570869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.
    Wool GD; Vaisar T; Reardon CA; Getz GS
    J Lipid Res; 2009 Sep; 50(9):1889-900. PubMed ID: 19433476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.